Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Solary

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Cell Death & Disease|February 14, 2024
Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkersFrançois-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Cell Death & Disease|March 12, 2021
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkersFrançois-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Ebiomedicine|June 1, 2022
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patientsNicolas Chapuis, Nusaibah Ibrahimi, Thibaut Belmondo, et al.
Molecular Oncology|August 5, 2020
Towards a cancer mission in Horizon Europe: recommendationsAnton Berns, Ulrik Ringborg, Julio E Celis, et al.
Biological Reviews of the Cambridge Philosophical Society|May 9, 2023
Reuniting philosophy and science to advance cancer researchThomas Pradeu, Bertrand Daignan-Fornier, Andrew Ewald, et al.
Nature Communications|April 8, 2024
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutationDavid Rombaut, Carine Lefèvre, Tony Rached, et al.
Cell|August 19, 2020
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2019
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung CancerGonzalo Recondo, Laura Mezquita, Francesco Facchinetti, et al.
BMC Cancer|September 24, 2022
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromesTamara K Moyo, Jason H Mendler, Raphael Itzykson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic LeukemiaLuca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Cell Death & Disease|February 14, 2024
Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkersFrançois-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Cell Death & Disease|March 12, 2021
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkersFrançois-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Ebiomedicine|June 1, 2022
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patientsNicolas Chapuis, Nusaibah Ibrahimi, Thibaut Belmondo, et al.
Molecular Oncology|August 5, 2020
Towards a cancer mission in Horizon Europe: recommendationsAnton Berns, Ulrik Ringborg, Julio E Celis, et al.
Biological Reviews of the Cambridge Philosophical Society|May 9, 2023
Reuniting philosophy and science to advance cancer researchThomas Pradeu, Bertrand Daignan-Fornier, Andrew Ewald, et al.
Nature Communications|April 8, 2024
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutationDavid Rombaut, Carine Lefèvre, Tony Rached, et al.
Cell|August 19, 2020
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2019
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung CancerGonzalo Recondo, Laura Mezquita, Francesco Facchinetti, et al.
BMC Cancer|September 24, 2022
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromesTamara K Moyo, Jason H Mendler, Raphael Itzykson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic LeukemiaLuca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Pageof 28